NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
6.09
+0.05 (0.83%)
At close: Aug 28, 2026, 4:00 PM EDT
6.08
-0.01 (-0.16%)
After-hours: Aug 28, 2026, 7:30 PM EDT
NextCure Employees
NextCure had 40 employees as of December 31, 2025. The number of employees decreased by 3 or -6.98% compared to the previous year.
Employees
40
Change (1Y)
-3
Growth (1Y)
-6.98%
Revenue / Employee
n/a
Profits / Employee
-$1,068,700
Market Cap
27.88M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 40 | -3 | -6.98% |
| Dec 31, 2024 | 43 | -39 | -47.56% |
| Dec 31, 2023 | 82 | -17 | -17.17% |
| Dec 31, 2022 | 99 | 12 | 13.79% |
| Dec 31, 2021 | 87 | -3 | -3.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evaxion | 46 |
| BeyondSpring | 44 |
| Quantum BioPharma | 17 |
| Lantern Pharma | 16 |
| Atossa Therapeutics | 16 |
| Barinthus Biotherapeutics | 14 |
| NanoViricides | 7 |
NXTC News
- 19 days ago - Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001 - PRNewsWire
- 23 days ago - NextCure reports Q2 EPS ($2.80), consensus ($1.92) - TheFly
- 23 days ago - NextCure Quarterly report: Q2 2026 - Filings
- 23 days ago - NextCure Earnings release: Q2 2026 - Filings
- 23 days ago - NextCure Slides: Corporate presentation - Filings
- 6 weeks ago - NextCure trading resumes - TheFly
- 6 weeks ago - NextCure trading halted, volatility trading pause - TheFly
- 6 weeks ago - Why Is Penny Stock NextCure (NXTC) Up Today? - TipRanks